The Why Files Blog
Advance against ALS?
Posted March 11th, 2009
In February, Cytotherapy published a Mexican study of an adult stem cell transplant for ALS, Lou Gehrig’s disease, with 5 control and 5 treated patients. Both survival and quality of life were much higher in the treated group. After 32 months, all control patients were dead, but 2 of the stem cell recipients were still alive 70 months after transplant. The study is the most convincing evidence to date that stem cells may be able to slow down this devastating, fatal disease.
Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients, Cytotherapy, Hector R. Martinez et al, 2/2009.
